QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)
QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)
QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)
QQQ   425.15 (-0.16%)
AAPL   166.99 (-0.60%)
MSFT   408.17 (-0.89%)
META   506.84 (+2.56%)
GOOGL   156.21 (+0.48%)
AMZN   180.66 (-0.34%)
TSLA   150.39 (-3.26%)
NVDA   851.53 (+1.33%)
AMD   155.28 (+0.82%)
NIO   4.04 (+3.32%)
BABA   69.04 (+0.32%)
T   16.21 (+0.56%)
F   12.05 (+0.08%)
MU   112.80 (-3.03%)
GE   155.60 (-0.04%)
CGC   7.92 (+22.03%)
DIS   113.31 (+0.33%)
AMC   2.92 (-2.01%)
PFE   25.30 (-0.47%)
PYPL   62.48 (-1.23%)
XOM   118.64 (+0.01%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$282.11
-3.0%
$331.66
$261.59
$489.36
$8.05B0.87199,433 shs219,257 shs
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
$14.76
$1.87B0.193.08 million shs3.45 million shs
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
C$13.60
C$7.13
C$590.00
C$317.06MN/A8,002 shs921 shs
Target Hospitality Corp. stock logo
TH
Target Hospitality
$10.81
+1.6%
$9.74
$8.49
$16.80
$1.09B2.09567,462 shs125,312 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-0.71%-12.17%-12.79%-4.38%-39.31%
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%+2.08%
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
0.00%0.00%0.00%0.00%0.00%
Target Hospitality Corp. stock logo
TH
Target Hospitality
+1.00%-2.12%+22.44%+14.78%-17.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6507 of 5 stars
3.44.00.04.21.83.31.9
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.0624 of 5 stars
1.00.00.00.00.63.30.0
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
2.367 of 5 stars
1.35.00.00.03.71.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0065.89% Upside
BELLUS Health Inc. stock logo
BLU
BELLUS Health
2.00
Hold$14.750.07% Upside
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
2.50
Moderate Buy$11.001.76% Upside

Current Analyst Ratings

Latest BIO, PLI, TH, BLU, and SPL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
Target Hospitality Corp. stock logo
TH
Target Hospitality
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$13.00 ➝ $12.00
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
3/26/2024
Target Hospitality Corp. stock logo
TH
Target Hospitality
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$13.00
3/25/2024
Target Hospitality Corp. stock logo
TH
Target Hospitality
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$12.00 ➝ $10.00
3/14/2024
Target Hospitality Corp. stock logo
TH
Target Hospitality
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $13.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B3.01$11.67 per share24.18$306.51 per share0.92
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$15K124,613.93N/AN/A$3.09 per share4.77
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
C$39.91M0.00N/A3.94C$6.07 per share0.00
Target Hospitality Corp. stock logo
TH
Target Hospitality
$563.61M1.93$2.56 per share4.22$3.71 per share2.91

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.62N/A-23.86%3.90%2.77%5/2/2024 (Estimated)
BELLUS Health Inc. stock logo
BLU
BELLUS Health
-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/A
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A-C$63.06N/AN/AN/AN/AN/AN/AN/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
$173.70M$1.547.0215.671.1029.53%53.91%24.85%5/14/2024 (Estimated)

Latest BIO, PLI, TH, BLU, and SPL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/13/2024Q4 2023
Target Hospitality Corp. stock logo
TH
Target Hospitality
$0.24$0.29+$0.05$0.29$118.00 million$126.20 million    
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/A
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/AN/AN/AN/AN/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/A
33.42
33.42
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
37.47
4.06
3.66
Target Hospitality Corp. stock logo
TH
Target Hospitality
0.47
2.57
2.57

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
BELLUS Health Inc. stock logo
BLU
BELLUS Health
90.37%
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
32.40%

Insider Ownership

CompanyInsider Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.06%
BELLUS Health Inc. stock logo
BLU
BELLUS Health
24.17%
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
N/A
Target Hospitality Corp. stock logo
TH
Target Hospitality
68.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.65 millionOptionable
BELLUS Health Inc. stock logo
BLU
BELLUS Health
74126.81 million96.16 millionNot Optionable
ProMetic Life Sciences Inc. stock logo
PLI
ProMetic Life Sciences
48723.31 millionN/ANot Optionable
Target Hospitality Corp. stock logo
TH
Target Hospitality
984100.52 million31.97 millionNot Optionable

BIO, PLI, TH, BLU, and SPL Headlines

SourceHeadline
Jason P. Vlacich Implements A Sell Strategy: Offloads $582K In Target Hospitality StockJason P. Vlacich Implements A Sell Strategy: Offloads $582K In Target Hospitality Stock
benzinga.com - April 16 at 12:41 PM
1,349,167 Shares in Target Hospitality Corp. (NASDAQ:TH) Bought by Voss Capital LLC1,349,167 Shares in Target Hospitality Corp. (NASDAQ:TH) Bought by Voss Capital LLC
marketbeat.com - April 15 at 7:42 PM
Target Hospitality (NASDAQ:TH) Earns Hold Rating from Stifel NicolausTarget Hospitality (NASDAQ:TH) Earns Hold Rating from Stifel Nicolaus
americanbankingnews.com - April 14 at 4:50 AM
Bournemouth vs Man Utd live: Score and latest updates from Vitality StadiumBournemouth vs Man Utd live: Score and latest updates from Vitality Stadium
msn.com - April 13 at 11:02 PM
Vanguard Group Inc. Acquires 523,398 Shares of Target Hospitality Corp. (NASDAQ:TH)Vanguard Group Inc. Acquires 523,398 Shares of Target Hospitality Corp. (NASDAQ:TH)
marketbeat.com - April 13 at 4:31 AM
Target Hospitality Corp. (NASDAQ:TH) Short Interest Down 37.7% in MarchTarget Hospitality Corp. (NASDAQ:TH) Short Interest Down 37.7% in March
marketbeat.com - April 12 at 3:16 PM
Hold Rating Maintained Amidst Acquisition Bid and Growth Prospects for Target HospitalityHold Rating Maintained Amidst Acquisition Bid and Growth Prospects for Target Hospitality
markets.businessinsider.com - April 12 at 11:57 AM
The Analyst Landscape: 4 Takes On Target HospitalityThe Analyst Landscape: 4 Takes On Target Hospitality
markets.businessinsider.com - April 12 at 11:57 AM
DocuSign upgraded, Arista downgraded: Wall Streets top analyst callsDocuSign upgraded, Arista downgraded: Wall Street's top analyst calls
finance.yahoo.com - April 12 at 11:57 AM
Target Hospitalitys (TH) "Hold" Rating Reiterated at Stifel NicolausTarget Hospitality's (TH) "Hold" Rating Reiterated at Stifel Nicolaus
marketbeat.com - April 12 at 8:23 AM
Target Hospitality Announces Partnership with Chard Métis Dene GroupTarget Hospitality Announces Partnership with Chard Métis Dene Group
finance.yahoo.com - April 12 at 6:57 AM
Target Hospitality Announces Partnership with Chard Métis Dene GroupTarget Hospitality Announces Partnership with Chard Métis Dene Group
prnewswire.com - April 12 at 6:45 AM
Rosie Holidays opens new gallery to mark its 50th anniversaryRosie Holidays opens new gallery to mark its 50th anniversary
fbcnews.com.fj - April 11 at 10:48 PM
Wall Street Favorites: 3 Under-$20 Stocks With Strong Buy Ratings for April 2024Wall Street Favorites: 3 Under-$20 Stocks With Strong Buy Ratings for April 2024
investorplace.com - April 11 at 1:46 PM
Target Hospitality Corp (TH)Target Hospitality Corp (TH)
investing.com - April 11 at 12:47 PM
Kent Lake Capital LLC Lowers Position in Target Hospitality Corp. (NASDAQ:TH)Kent Lake Capital LLC Lowers Position in Target Hospitality Corp. (NASDAQ:TH)
marketbeat.com - April 6 at 7:36 PM
Why Target Hospitality Stock Surged Higher This WeekWhy Target Hospitality Stock Surged Higher This Week
fool.com - March 28 at 1:31 PM
Target Hospitality Corp.Target Hospitality Corp.
cnn.com - March 27 at 10:24 AM
Target Hospitalitys (TH) "Buy" Rating Reaffirmed at Stifel NicolausTarget Hospitality's (TH) "Buy" Rating Reaffirmed at Stifel Nicolaus
marketbeat.com - March 26 at 10:46 AM
Arrow offers to buy remaining stake Target HospitalityArrow offers to buy remaining stake Target Hospitality
msn.com - March 25 at 7:51 PM
Target Hospitality jumps after $10.80 a share takeover offerTarget Hospitality jumps after $10.80 a share takeover offer
msn.com - March 25 at 7:51 PM
Target Hospitality (NASDAQ:TH) PT Lowered to $10.00Target Hospitality (NASDAQ:TH) PT Lowered to $10.00
marketbeat.com - March 25 at 8:48 AM
Target Hospitality Receives Buyout Offer from TDR CapitalTarget Hospitality Receives Buyout Offer from TDR Capital
prnewswire.com - March 25 at 8:40 AM
Target Hospitality (TH) Surges 6.5%: Is This an Indication of Further Gains?Target Hospitality (TH) Surges 6.5%: Is This an Indication of Further Gains?
zacks.com - March 21 at 2:51 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
BELLUS Health logo

BELLUS Health

NASDAQ:BLU
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.
ProMetic Life Sciences logo

ProMetic Life Sciences

TSE:PLI
Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.
Target Hospitality logo

Target Hospitality

NASDAQ:TH
Target Hospitality Corp. operates as a specialty rental and hospitality services company in North America. The company operates through two segments, Hospitality & Facilities Services - South and Government. It owns a network of specialty rental accommodation units. In addition, the company provides catering and food, maintenance, housekeeping, grounds-keeping, security, health and recreation facilities, workforce community management, concierge, and laundry services. It serves the U.S. government contractors and investment grade natural resource development companies. Target Hospitality Corp. was founded in 1978 and is headquartered in The Woodlands, Texas.